{"anticipatedPostingDate":"2025-12","denomUnitsSelected":"Participants","description":"TSST was defined as time from randomization to the start date of the second subsequent anti-cancer therapy after discontinuation of randomized treatment or death due to any cause.","reportingStatus":"NOT_POSTED","timeFrame":"From Day 1 up to 64 months","title":"Time to Second Subsequent Treatment or Death (TSST) in the Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-low and Intent-to-Treat Population","type":"SECONDARY"}